Irwin Lucki
#124,299
Most Influential Person Now
Researcher
Irwin Lucki's AcademicInfluence.com Rankings
Irwin Luckibiology Degrees
Biology
#7745
World Rank
#10712
Historical Rank
Neuroscience
#1030
World Rank
#1072
Historical Rank
Download Badge
Chemistry Biology
Irwin Lucki's Degrees
- Masters Biology Stanford University
Similar Degrees You Can Earn
Why Is Irwin Lucki Influential?
(Suggest an Edit or Addition)Irwin Lucki's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Assessing antidepressant activity in rodents: recent developments and future needs. (2002) (1518)
- Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants (1995) (1350)
- The spectrum of behaviors influenced by serotonin (1998) (1127)
- Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test (2005) (1028)
- The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. (1997) (813)
- 5-HT1A receptor function in major depressive disorder (2009) (498)
- Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice (2001) (489)
- Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test (1999) (375)
- Adult hippocampal neurogenesis: Regulation, functional implications, and contribution to disease pathology (2009) (375)
- Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects (2005) (353)
- Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth (1995) (339)
- Strain Differences in the Behavioral Effects of Antidepressant Drugs in the Rat Forced Swimming Test (1997) (334)
- cAMP Response Element-Binding Protein Is Essential for the Upregulation of Brain-Derived Neurotrophic Factor Transcription, But Not the Behavioral or Endocrine Responses to Antidepressant Drugs (2002) (333)
- Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. (1997) (313)
- Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment (2005) (312)
- Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors. (2000) (312)
- Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat. (1984) (305)
- Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. (1995) (281)
- Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. (2004) (259)
- Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test (1998) (252)
- Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants (2013) (247)
- Effects of Corticotropin-Releasing Factor on Brain Serotonergic Activity (1998) (235)
- High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice (2014) (235)
- Regional differences in the effects of forced swimming on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid (1995) (230)
- The role of serotonin receptor subtypes in treating depression: a review of animal studies (2011) (216)
- Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice. (2001) (210)
- Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei. (1994) (205)
- The effects of different stressors on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid (1997) (201)
- Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs. (2000) (201)
- Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test. (2002) (198)
- Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity. (1989) (197)
- Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments (2008) (193)
- Effects of diabetes on hippocampal neurogenesis: Links to cognition and depression (2013) (192)
- Amplified behavioral and endocrine responses to forced swim stress in the Wistar–Kyoto rat (2002) (178)
- Regulation of Serotonin Release in the Lateral Septum and Striatum by Corticotropin-Releasing Factor (2001) (172)
- Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test (2007) (171)
- Antidepressant-like behavioral effects of serotonin receptor agonists (1994) (159)
- Cosyntropin (ACTH alpha 1-24) stimulation test in depressed patients and healthy subjects. (1983) (158)
- Interaction between the forced swimming test and fluoxetine treatment on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the rat. (1997) (153)
- Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test (2005) (152)
- Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs. (2001) (148)
- Serotonergic involvement in haloperidol-induced catalepsy. (1993) (148)
- Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals. (2000) (138)
- [99mTc]TRODAT-1: A novel technetium-99m complex as a dopamine transporter imaging agent (1997) (133)
- Antidepressant-like activity of 5-HT1A agonists measured with the forced swim test (2005) (123)
- Early life protein restriction alters dopamine circuitry (2010) (121)
- 5-HT1 receptors and behavior (1992) (121)
- Murine models of depression (1999) (120)
- Abnormal salivary cortisol levels in social phobic patients in response to acute psychological but not physical stress (2001) (120)
- Corticotropin-releasing factor in the dorsal raphe nucleus: Linking stress coping and addiction (2010) (118)
- HDAC6 Regulates Glucocorticoid Receptor Signaling in Serotonin Pathways with Critical Impact on Stress Resilience (2012) (117)
- Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in Wistar Kyoto Rats (2010) (116)
- Evidence for corticotropin-releasing factor regulation of serotonin in the lateral septum during acute swim stress: adaptation produced by repeated swimming (2002) (116)
- Regulation of extracellular concentrations of 5-hydroxytryptamine (5-HT) in mouse striatum by 5-HT(1A) and 5-HT(1B) receptors. (2000) (110)
- Behavioral analysis of CREB αΔ mutation on a B6/129 F1 hybrid background (2002) (108)
- Automated tests for measuring the effects of antidepressants in mice (2004) (108)
- NIDDK International Conference Report on Diabetes and Depression: Current Understanding and Future Directions (2014) (104)
- Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents (2007) (101)
- Increasing the Levels of Insulin-Like Growth Factor-I by an IGF Binding Protein Inhibitor Produces Anxiolytic and Antidepressant-Like Effects (2007) (101)
- cAMP Response Element-Binding Protein Deficiency Allows for Increased Neurogenesis and a Rapid Onset of Antidepressant Response (2007) (99)
- Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists (1995) (98)
- Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse. (2001) (96)
- Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance. (2000) (94)
- Sex Differences in the Regulation of Serotonergic Transmission and Behavior in 5-HT Receptor Knockout Mice (2005) (93)
- Effects of Acute and Chronic Reboxetine Treatment on Stress-induced Monoamine Efflux in the Rat Frontal Cortex (2002) (92)
- Antidepressant-like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors (2016) (92)
- Chronic use of benzodiazepines and psychomotor and cognitive test performance (2004) (89)
- Behavioral and Neurochemical Effects of 5-{4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl}-benzofuran-2-carboxamide (EMD 68843): A Combined Selective Inhibitor of Serotonin Reuptake and 5-Hydroxytryptamine1A Receptor Partial Agonist (2002) (88)
- Sex-Specific Effects of Chronic Fluoxetine Treatment on Neuroplasticity and Pharmacokinetics in Mice (2010) (86)
- A neuroendocrine test battery in bipolar patients and healthy subjects. (1983) (84)
- The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release (1993) (84)
- A role for the subthalamic nucleus in 5-HT2C-induced oral dyskinesia (1996) (83)
- Effects of cocaine on extracellular dopamine and serotonin levels in the nucleus accumbens (2001) (82)
- Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats (2011) (81)
- Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice (2015) (80)
- Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function (2012) (79)
- Resistance to the anti-anxiety effect of buspirone in patients with a history of benzodiazepine use. (1986) (75)
- Potential antidepressant effects of novel tropane compounds, selective for serotonin or dopamine transporters. (1997) (73)
- Distinguishing roles for norepinephrine and serotonin in the behavioral effects of antidepressant drugs. (2004) (70)
- Behavioral and neurochemical effects of chronic administration of reserpine and SKF-38393 in rats. (1991) (67)
- Reversal of dopamine system dysfunction in response to high fat diet (2013) (67)
- Limitations on the use of the C57BL/6 mouse in the tail suspension test (2001) (66)
- Differential effects of the anxiolytic drugs, diazepam and buspirone, on memory function. (1987) (64)
- Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse. (2001) (64)
- Serotonin receptor specificity in anxiety disorders. (1996) (63)
- Dysregulation of the Lateral Habenula in Major Depressive Disorder (2018) (63)
- Comparison of the kappa-opioid receptor antagonist DIPPA in tests of anxiety-like behavior between Wistar Kyoto and Sprague Dawley rats (2010) (60)
- Fluoxetine treatment induces dose dependent alterations in depression associated behavior and neural plasticity in female mice (2010) (58)
- Increased sensitivity to d-and l-amphetamine action after midbrain raphe lesions as measured by locomotor activity (1979) (58)
- A prescription to resist proscriptions for murine models of depression (2001) (57)
- Effects of intrabulbar injections of 6-hydroxydopamine on ethyl acetate odor detection in castrate and non-castrate male rats (1988) (57)
- Enhanced Sensitivity of the MRL/MpJ Mouse to the Neuroplastic and Behavioral Effects of Chronic Antidepressant Treatments (2008) (57)
- The effect of repeated exposure to forced swimming on extracellular levels of 5-hydroxytryptamine in the rat. (1998) (56)
- Behavioral analysis of CREB alphadelta mutation on a B6/129 F1 hybrid background. (2002) (55)
- Antidepressant-like behavioral effects of IGF-I produced by enhanced serotonin transmission. (2008) (55)
- Differential regulation of dopamine D2 and D3 receptors by chronic drug treatments. (2000) (55)
- Pharmacogenomic Evaluation of the Antidepressant Citalopram in the Mouse Tail Suspension Test (2006) (55)
- Rapid discrimination of the stimulus properties of 5-hydroxytryptamine agonists using conditioned taste aversion. (1988) (54)
- Dopaminergic Stimulation of Subthalamic Nucleus Elicits Oral Dyskinesia in Rats (1994) (52)
- Development of selective tolerance to the serotonin behavioral syndrome and suppression of locomotor activity after repeated administration of either 5-MeODMT or mCPP. (1985) (52)
- Targeting opioid dysregulation in depression for the development of novel therapeutics. (2019) (52)
- A role for the mu opioid receptor in the antidepressant effects of buprenorphine (2017) (51)
- Effect of chronic treatments with tandospirone and imipramine on serotonin-mediated behavioral responses and monoamine receptors (1993) (50)
- Neurochemical changes associated with the persistence of spontaneous oral dyskinesia in rats following chronic reserpine treatment (1991) (50)
- Anxiolytic effect of serotonin depletion in the novelty-induced hypophagia test (2007) (50)
- Psychomotor performance of long-term benzodiazepine users before, during, and after benzodiazepine discontinuation. (1999) (49)
- Reversal of Stress-Induced Social Interaction Deficits by Buprenorphine (2017) (49)
- Somatostatin receptors in the nucleus accumbens selectively mediate the stimulatory effect of somatostatin on locomotor activity in rats. (1993) (49)
- Depressive phenotypes evoked by experimental diabetes are reversed by insulin (2012) (49)
- Removal of high-fat diet after chronic exposure drives binge behavior and dopaminergic dysregulation in female mice (2016) (48)
- Serotonergic properties of cocaine: Effects on a 5-HT2 receptor-mediated behavior and on extracellular concentrations of serotonin and dopamine (1994) (48)
- Flow cytometric analysis of BrdU incorporation as a high-throughput method for measuring adult neurogenesis in the mouse. (2009) (47)
- Antidepressant-like activity of compounds with varying efficacy at 5-HT1A receptors (1993) (47)
- A role for corticotropin-releasing factor signaling in the lateral habenula and its modulation by early-life stress (2018) (46)
- 5-Hydroxytryptamine1A receptors and behavioral responses. (1990) (45)
- Corticotropin-releasing factor in the dorsal raphe nucleus regulates activity of lateral septal neurons (2003) (44)
- Anatomical differentiation within the nucleus accumbens of the locomotor stimulatory actions of selective dopamine agonists andd-amphetamine (2005) (44)
- The role of noradrenergic tone in the dorsal raphe nucleus of the mouse in the acute behavioral effects of antidepressant drugs (2007) (43)
- Cognitive and psychomotor effects of paroxetine and sertraline on healthy elderly volunteers. (2001) (43)
- Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors (1992) (43)
- 5-HT4 receptors do not mediate the antidepressant-like behavioral effects of fluoxetine in a modified forced swim test. (2000) (43)
- Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in a rat model of antidepressant action (2002) (43)
- Opportunities to discover genes regulating depression and antidepressant response from rodent behavioral genetics. (2005) (42)
- Desensitization of 5-HT1A autoreceptors by chronic administration of 8-OH-DPAT (1992) (42)
- Behavioral studies of serotonin receptor agonists as antidepressant drugs. (1991) (41)
- Regulation of Serotonin Receptors and Responsiveness in the Brain (1988) (41)
- Sucrose intake and fasting glucose levels in 5-HT1A and 5-HT1B receptor mutant mice (2008) (40)
- Overlapping and Distinct Brain Regions Associated with the Anxiolytic Effects of Chlordiazepoxide and Chronic Fluoxetine (2008) (40)
- Antidepressant-like effects of buprenorphine in rats are strain dependent (2015) (39)
- Neuroendocrine regulation in depressed postmenopausal women and healthy subjects (1983) (39)
- Serotonin-induced head shaking behavior in rats does not involve receptors located in the frontal cortex (1987) (39)
- Brain Serotonin2 and Serotonin1A Receptors Are Altered in the Congenitally Hyperammonemic Sparse Fur Mouse (1992) (39)
- The 5-HT1A Receptor Antagonist p-MPPI Blocks Responses Mediated by Postsynaptic and Presynaptic 5-HT1A Receptors (1997) (38)
- Kappa Opioid Receptor Antagonists as Potential Therapeutics for Stress-Related Disorders. (2020) (37)
- Social competition in rats: Cell proliferation and behavior (2006) (35)
- The behavioral effects of benzodiazepines following long-term use. (1986) (35)
- Ketamine Reverses Lateral Habenula Neuronal Dysfunction and Behavioral Immobility in the Forced Swim Test Following Maternal Deprivation in Late Adolescent Rats (2018) (35)
- Chronic corticosterone exposure alters postsynaptic protein levels of PSD‐95, NR1, and synaptopodin in the mouse brain (2011) (35)
- Behavioral Models of Serotonin Receptor Activation (1988) (33)
- Control rate of response or reinforcement and amphetamine's effect on behavior. (1983) (33)
- Strain differences in the effects of chronic corticosterone exposure in the hippocampus (2012) (33)
- Growth hormone, prolactin and thyrotropin responses to gonadotropin-releasing hormone in depressed patients and healthy volunteers (1982) (32)
- Intracerebral microdialysis during deep brain stimulation surgery (2010) (32)
- Psychomotor performance following the long-term use of benzodiazepines. (1985) (32)
- Differential blockade of CRF-evoked behaviors by depletion of norepinephrine and serotonin in rats (2008) (29)
- Prevention of the serotonin syndrome in rats by repeated administration of monoamine oxidase inhibitors but not tricyclic antidepressants (2004) (27)
- SSRIs do not cause affective blunting in healthy elderly volunteers. (2004) (26)
- Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism (2017) (25)
- Rate-dependent effects of amphetamine on responding under random-interval schedules of reinforcement in the rat (1983) (25)
- Reduction of feeding behavior by the serotonin uptake inhibitor sertraline (2004) (25)
- Hair corticosterone measurement in mouse models of type 1 and type 2 diabetes mellitus (2017) (21)
- Novel Targets to Treat Depression: Opioid-Based Therapeutics. (2020) (21)
- Variations in the behavioral responses to apomorphine in different strains of rats (1995) (21)
- Alterations in monoamine-containing neuronal function due to administration of antidepressants repeatedly to rats. (2009) (18)
- Corticotropin-releasing Factor in the Rat Dorsal Raphe Nucleus Promotes Different Forms of Behavioral Flexibility Depending on Social Stress History (2015) (18)
- Electrophysiological and behavioral responses to ketamine in mice with reduced Akt1 expression (2013) (18)
- Hormonal and behavioral effects associated with intravenousl-tryptophan administration (2004) (17)
- Pharmacokinetic and Pharmacodynamic Evaluation of the Potential Drug Interaction Between Venlafaxine and Diazepam (1995) (17)
- The effect of anxiolytic drugs on memory in anxious subjects. (1988) (17)
- The acute effects of antidepressant drugs on the performance of conditioned avoidance behavior in rats (1985) (17)
- Behavioral effects of 8-OH-DPAT: studies using the Microtaxic Ventricular Injector (1989) (17)
- Corticosterone exposure augments sensitivity to the behavioral and neuroplastic effects of fluoxetine in C57BL/6 mice (2016) (16)
- Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine (1990) (16)
- The 5-HT1A receptor modulates the effects of cocaine on extracellular serotonin and dopamine levels in the nucleus accumbens. (2005) (16)
- The ACTH stimulation test in depression. (1985) (16)
- The Role of Serotonin in Depression (2010) (16)
- Variation in the genes encoding vesicular monoamine transporter 2 and beta-1 adrenergic receptor and antidepressant treatment outcome (2008) (16)
- VMAT1 deletion causes neuronal loss in the hippocampus and neurocognitive deficits in spatial discrimination (2013) (16)
- Changes in behavioral sensitivity to SKF-38393 and quinpirole following withdrawal from continuous cocaine administration in rats (1996) (16)
- Altered behavioral responses mediated by serotonin receptors in the genetically dystonic (dt) rat (1991) (15)
- Indomethacin reverses decreased hippocampal cell proliferation in streptozotocin-induced diabetic mice (2015) (14)
- Opioid modulation of cognitive impairment in depression. (2018) (14)
- The kappa opioid receptor antagonist aticaprant reverses behavioral effects from unpredictable chronic mild stress in male mice (2020) (12)
- Discriminated taste aversion with a 5-HT(1A) agonist measured using saccharin preference. (1991) (12)
- Dexras1 a unique ras-GTPase interacts with NMDA receptor activity and provides a novel dissociation between anxiety, working memory and sensory gating (2016) (11)
- Vendor differences in anxiety-like behaviors in female and male Sprague Dawley rats (2020) (10)
- VENLAFAXINE PHARMACOKINETICS AND PHARMACODYNAMICS (1992) (10)
- Effects of Serotonin-Related Gene Deletion on Measures of Anxiety, Depression, and Neurotransmission (2006) (9)
- Performance and extinction of lever press behavior following chronic administration of desipramine to rats (2004) (9)
- Choice responding following multiple schedule training (1980) (8)
- Behavioral effects of the kappa opioid receptor partial agonist nalmefene in tests relevant to depression. (2020) (8)
- D-serine deficiency attenuates the behavioral and cellular effects induced by the hallucinogenic 5-HT2A receptor agonist DOI (2014) (8)
- Developmental Alterations in 5-Hydroxytryptamine Concentration and Turnover after Treatment of Neonatal Rats with 5,7-Dihydroxytryptamine (1996) (8)
- Brain monoamines and antidepressant-like responses in MRL/MpJ versus C57BL/6J mice (2013) (8)
- Differential craving between recovering abstinent alcoholic-dependent subjects and therapeutic users of benzodiazepines. (1990) (8)
- Selective Enhancement of Grooming Behavior by the D‐1 Agonist SKF 38393 in Rats following the Destruction of Serotonin Neurons a (1988) (7)
- Discriminative stimulus properties of the benzodiazepine receptor antagonist flumazenil (2005) (7)
- Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors (2022) (6)
- The long-term effects of diazepam and pentylenetetrazol on behavioral sensitivity to a stressor (1987) (5)
- Discriminative stimulus properties of the serotonin uptake inhibitor sertraline. (1994) (5)
- Buprenorphine prevents stress-induced blunting of nucleus accumbens dopamine response and approach behavior to food reward in mice (2019) (5)
- Deletion of the vesicular monoamine transporter 1 (vmat1/slc18a1) gene affects dopamine signaling (2019) (5)
- Addressing the Opioid Crisis: Medical Student Instruction in Opioid Drug Pharmacology, Pain Management, and Substance Use Disorders (2019) (5)
- Antidepressant drugs: effects on beta-adrenergic and serotonineregic receptors. (1982) (5)
- Protracted Effects of Ketamine Require Immediate Kappa Opioid Receptor Activation and Long‐Lasting Desensitization (2020) (5)
- Kappa Opioid Receptors in the Pathology and Treatment of Major Depressive Disorder. (2021) (4)
- Sex differences in the modulation of mouse nest building behavior by kappa opioid receptor signaling (2020) (4)
- Differential tolerance to the effects of chlordiazepoxide on unpunished and punished operant responding following chronic treatment (1996) (4)
- Serotonin revisited (2010) (3)
- Editorial: Reporting guidelines for psychopharmacology (2016) (3)
- Buprenorphine as a Treatment for Major Depression and Opioid Use Disorder (2022) (3)
- Long-term increase in sensitivity to ketamine's behavioral effects in mice exposed to mild blast induced traumatic brain injury (2021) (3)
- Continuous light paradoxically reduces catecholamine-induced melatonin production (1983) (3)
- Discriminative stimulus properties of the benzodiazepine receptor inverse agonist methyl-6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate (DMCM) (2005) (2)
- The role of the aural head shake reflex in serotonin-mediated head shaking behavior (2004) (2)
- Antinociceptive and Analgesic Effects of (2R,6R)-Hydroxynorketamine (2022) (2)
- Increased sensitivity to benzodiazepine antagonists in rats following chronic treatment with a low dose of diazepam (2005) (2)
- Differential regulation of the behavioral effects of chlordiazepoxide (1994) (2)
- Behavioral Facilitation (2006) (2)
- Translational relevance of fear conditioning in rodent models of mild traumatic brain injury (2021) (2)
- Depression: Animal Models (2014) (1)
- Genetic Models of Depression and Antidepressant Response (2010) (1)
- Behavioral effects of alprazolam in chronic therapeutic users. (1989) (1)
- P31 REDUCED NEUROGENESIS BY SUBORDINATE RATS IN SOCIAL COMPETITION (2004) (1)
- Long-term effects of yohimbine on behavioral sensitivity to a stressor (2004) (1)
- The role of norepinephrine and serotonin in behavioral models of depression (2000) (0)
- Desvenlafaxine (2018) (0)
- (2R,6R)-hydroxynorketamine (HNK) reverses mechanical hypersensitivity in a model of localized inflammatory pain (2022) (0)
- The tryptophan hydroxylase 2 (Tph2) polymorphism C2432T mediates mRNA expression and responses to antidepressant treatment in a sex‐specific manner (2013) (0)
- P.1.000 Sex differences in stress-induced depression (2003) (0)
- Development of selective behavioral tolerance following the repeated administration of serotonin agonists (1985) (0)
- Editorial: Reporting guidelines for psychopharmacology (2016) (0)
- S56 ARE CHRONIC MODELS OF DEPRESSION BETTER THAN ACUTE SCREENING TESTS (2005) (0)
- Sex Differences in Kappa Opioid Receptor Modulation of Nest Building Behavior in Mice (2019) (0)
- Indomethacin reverses decreased hippocampal cell proliferation in streptozotocin-induced diabetic mice (2014) (0)
- Addressing the Opioid Crisis: Medical Student Instruction in Opiate Drug Pharmacology and Pain Management (2019) (0)
- Gepirone in Depression and Anxiety Disorders An Initial Appraisal of its Clinical Potential (1994) (0)
- Electrophysiological and behavioral responses to ketamine in mice with reduced Akt1 expression (2013) (0)
- John A Harvey (2011) (0)
- The tryptophan hydroxylase 2 (Tph2) polymorphism C2432T mediates wound repair and behavioral responses to SSRIs in a sex‐specific manner (2012) (0)
- SYMPOSIUM N 7 DRUGS FOR THE TREATMENT OF MOOD DISORDERS ORGANIZERS: ALDO BADIANI & IRWIN (2013) (0)
- Behavioral effects of paroxetine and sertraline on healthy elderly volunteers (2001) (0)
- Hormone responses to GNRH To the editor: (1983) (0)
- Is the“new” more useful than the“old”? (1983) (0)
- Serotonergic mechanisms in models of depression (1997) (0)
- Regulation of corticotropin-releasing factor (CRF) neurotransmission in biogenic amine nuclei (2000) (0)
- Hormone responses to GNRH. (1983) (0)
- Preface (1994) (0)
- Pharmacogenetic Modulation of the Behavioral Effects of Buprenorphine in a Mouse Model of the OPRM 1 ( A 118 G ) Polymorphism (2016) (0)
- Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice (2014) (0)
- Increased CRF2 expression in the dorsal raphe is associated with passive behavioral responses to stress (2009) (0)
- Strain Differences Determine the Response to Citalopram on Hippocampal Neurogenesis, Neurotrophin Mobilization and Behavior (2011) (0)
- Discrimination of the benzodiazepine receptor antagonist Ro 15-1788 using the conditioned taste aversion procedure. (1989) (0)
- Special Section on The Opioid Crisis Addressing the Opioid Crisis: Medical Student Instruction in Opioid Drug Pharmacology, Pain Management, and Substance Use Disorders (2019) (0)
- GENETIC MODELS OF ANTIDEPRESSANT DRUG SENSITIVITY IN KNOCKOUT AND INBRED MOUSE STRAINS (1999) (0)
- EFFECTS OF FLUOXETINE TREATMENT ON EXTRACELLULAR 5‐HT AND BEHAVIORAL RESPONSES TO THE FORCED SWIMMINGTEST (1998) (0)
- Analgesic and Antinociceptive Effects of (2R,6R)‐hydroxynorketamine (HNK) in Mice (2022) (0)
- S.7.2 - DEVELOPMENT OF BUPRENORPHINE FOR TREATMENT-RESISTANT DEPRESSION (2013) (0)
- Epigenome-Wide Association Study of Individuals With Alcohol Use Disorder and Suicidal Behavior: Identification and Replication of TIMP2 as Novel Target (2020) (0)
- B. Kenneth Koe (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Irwin Lucki?
Irwin Lucki is affiliated with the following schools:
